govinfo:USCOURTS-caed-2_24-cv-03017-8

Corpus: 543,329 opinions · 3,179 judges · newest 2026-11-02 · expanding Coverage ↗

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

1
Order
Case No. 2:24-cv-03017-DJC-JDP

UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF CALIFORNIA

LACEY TIMMINS, on behalf of Herself
and all Others Similarly Situated,

Plaintiff,

UNILEVER UNITED STATES, INC.,

Defendant.

Case No. 2:24-cv-03017-DJC-JDP

ORDER GRANTING IN PART AND
DENYING IN PART PLAINTIFF’S
UNOPPOSED REQUEST TO SEAL
DOCUMENTS (ECF 52)

Action Filed: November 1, 2024

Dept.: Courtroom 7
Judge: Daniel J. Calabretta

Case 2:24-cv-03017-DJC-JDP Document 55 Filed 10/20/26 Page 1 of 5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

2
Order
Case No. 2:24-cv-03017-DJC-JDP
The Court has considered Plaintiff’s Unopp osed Request to Seal Documents (see
ECF 52) and Defendant Unilever Un ited States, Inc.’s Statement in Response to Plaintiff’s
Request to Seal Documents, together with th e Declaration of Naoki S. Kaneko and the
chart attached to Unilever’s Statement as Appendix A.
The Court finds that compelling reasons support sealing or redacting the material
identified below. The public’s interest in access to these materials is outweighed by the risk
of competitive harm to Unilever and to the non-parties whose information it contains. The
requested sealing is narrowly ta ilored: apart from the documents sealed in full or in
substantial part, it is limited to discrete words, figures, and i dentifiers, and the substance of
the parties’ arguments, the testimony, and the experts’ opinions remains public.
Accordingly, IT IS HEREBY ORDERED that the Request is GRANTED IN PART and
DENIED IN PART, as follows:
1. The following documents shall be filed und er seal in their entirety, or except
for the portions indicated:
Document Scope of Sealing Description
Ex. 25 — California sales
data by product
(UNITIMM_00000203)
Entire document Entire document (native spreadsheet
of non-public, product-level sales
data
).
Ex. 51 — Clinical study
brief
(UNITIMM_00000290–99)
Entire document Entire doc ument (internal clinical
study brief, including study planning,
product information, and vendor
pricin
g).
Ex. 59 — Givaudan Safety
Data Sheet for proprietary
fragrance
(UNITIMM_00001429–45)
Entire document
except the title and
date
All content except the document title
and date (including the fragrance’s
trade name).
Ex. 66 — Givaudan
Allergen Extended List
(UNITIMM_00001455–57)
Entire document
except the title and
issue date
All content except the document title
and issue date (including the
fra
grance’s trade name).
Case 2:24-cv-03017-DJC-JDP Document 55 Filed 10/20/26 Page 2 of 5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

3
Order
Case No. 2:24-cv-03017-DJC-JDP
Document Scope of Sealing Description
Ex. 67 — Buying
specification for Givaudan
fragrance
(UNITIMM_00001458–61)
Entire document
except the title and
dates
All content except the document title
and dates (including the fragrance’s
trade name).

2. The following documents shall be filed publicly with the redactions indicated,
and filed in unredacted form under seal:
Document Material to Be Redacted
Memorandum of Points and
Authorities ISO Motion for
Class Certification
Only the IQVIA survey figures at 4:20–21, 4:25, and
11:6.
Ex. A — Deposition of Kate
Godbout (Oct. 2, 2026)
(excerpts)
Words and figures only: the fragrance’s trade name at
208:4–5, 208:11, 221:4, 226:21, 228:1, and 228:8; the
fragrance-component names at 179:4–5, 179:17,
179:22, 181:20–21, 209:1, and 221:24; the
concentration figure at 209:2 and the specification value
at 221:24–25; and the IQVIA survey figures at 65:3–4,
65:17, 67:25, 68:16, and 69:19.
Ex. D — Report of Brandon
Adler, M.D.
The first sentence of ¶ 11; the first sentence of ¶ 12
(including footnote references 1, 25, 26); ¶ 14 in its
entirety (including footnote references 30 and 31); and,
in ¶ 13, the clause identifying a component as present
in the product. These passages identify components of
the proprietar
y fragrance.
Ex. F — Declaration of Colin
B. Weir
Only the IQVIA survey figures in ¶ 21 and n.15 (sample
sizes, recommendation rates, and percentages by
brand
).
Ex. 28 — IQVIA claim
validation statement (Mar. 13,
2025) (UNITIMM_00000007–
08
)
The survey results (sample size, recommendation
rates, and percentages, including competitor brands).
Ex. 29 — IQVIA claim
validation statement (Dec. 12,
2022) (UNITIMM_00000156–
57
)
The survey results (sample size, recommendation
rates, and percentages, including competitor brands).
Ex. 30 — IQVIA claim
validation statement (Dec. 21,
2023) (UNITIMM_00000158–
59
)
The survey results (sample size, recommendation
rates, and percentages, including competitor brands).
Case 2:24-cv-03017-DJC-JDP Document 55 Filed 10/20/26 Page 3 of 5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

4
Order
Case No. 2:24-cv-03017-DJC-JDP
Document Material to Be Redacted
Ex. 31 — Defendant’s Third
Amended Answers to
Interrogatories, Set One
The fragrance’s trade name wherever it appears, and
the fragrance-component table in the response to
Interrogatory No. 9 (component names, CAS numbers,
and concentrations). The product’s ingredient
percentages, including the fragrance load, may be filed
publicl
y.
Ex. 33 — Abbreviated Study
Report, HRIPT
(UNITIMM_00000009–16)
The fragrance’s trade name, the formula and batch
number, and internal safety-review (SEAC) reference
numbers
(UNITIMM_00000012, 16).
Ex. 38 — Email chain with
CRL re study setup
(UNITIMM_00001498–1516)
The research vendor’s per-subject price
(UNITIMM_00001513).
Ex. 48 — Email chain re
fragrance brief
(UNITIMM_00001466–71)
Fragrance cost targets and volume figures, and the
trade names of two predecessor Givaudan fragrances
(UNITIMM_00001466–69, 1471).
Ex. 60 — Email chain (Sept.
2018) (UNITIMM_00001517–
20
)
The fragrance’s trade name in the attachment line
(UNITIMM_00001517).
Ex. 70 — Email chain (Apr.–
May 2024)
(UNITIMM_00002044–46)
The fragrance’s trade name in the attachment filename
(UNITIMM_00002044) and at UNITIMM_00002045 and
the related specification number.
Ex. 71 — Fragrance brief
(Feb. 2024)
(UNITIMM_00002047–54)
Annual fragrance volume and cost-per-ton targets
(UNITIMM_00002048–49), the fragrance’s trade name
(UNITIMM_00002047, 2049), and the discussion of a
specific fra
grance ingredient (UNITIMM_00002051).

3. The Request is DENIED as to Exhibits 35, 36, 37, 39, 40, 41, 43, 53, and 69,
as to which Unilever has withdrawn its confident iality designation. Those materials shall be
filed publicly in unredacted form.
4. Within 7 days of this Or der, Plaintiff shall (a) subm it the documents identified
in paragraphs 1 and 2, in unredacted form, for filing under seal in accordance with Local
Rule 141(e)(2) and Section III of the Court’s Standi ng Order in Civil Case s; and (b) file on
the public docket redacted versions of the documents identified in paragraphs 1 and 2,
reflecting only the sealing and redactions approved in this Order, together with the
materials identified in paragraph 3.
Case 2:24-cv-03017-DJC-JDP Document 55 Filed 10/20/26 Page 4 of 5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

5
Order
Case No. 2:24-cv-03017-DJC-JDP
5. The sealed material shall remain under seal until further order of the Court.
Access shall be limited to the Court, its staff, and persons authorized to receive
Confidential material under the Stipulated Protective Order (ECF 29).
6. The parties shall file their request to seal, response and all supporting
documents submitted to the Court for review on the public docket forthwith.
IT IS SO ORDERED.

Dated: October 19, 2026 /s / Daniel J. Calabretta
THE HONORABLE DANIEL J. CALABRETTA
UNITED STATES DISTRICT JUDGE

Case 2:24-cv-03017-DJC-JDP Document 55 Filed 10/20/26 Page 5 of 5

Passage view · GavelSight